SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes

NCT02644122 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment

Conditions

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma

Interventions

DRUG: SF1126

Sponsor

Ezra Cohen

Collaborators

[object Object]